58. Kim H., Ann Y. Role of peroxisome proliferators-activated receptor-gamma in the glucose-sesing
apparatus of liver and beta-cells // Diabetes. — 2004; Vol.-53: S. 1.
59. KrugerT.H., Haake P., Hartmann U., Schedlowski M., Exton M.S. Orgasm-induced prolactin
secretion: feedback control of sexual drive? // Neurosci Biobehav. Rev. - 2002, Jan.; 26(1): 31-44.
60. KrugerT.H., Haake P., Haverkamp J., Kramer M., Exton M.S., Sailer В., Leygraf N., Hartmann U.,
Schedlowski M.J. Effects of acute prolactin manipulation on sexual drive and function in males //
Endocrinol. — 2003, Dec; 179(3): 357-65.
61. Leanos-Miranda A., Pascoe-Lira D., Chavez-Rueda K.A., Blanco-Favela F. Persistence of
macroprolactinaemia due to antiprolactin antibody before, during, and after pregnancy in a woman
with systemic lupus erythematosus // J. Clin. Endocrinol. Metab. - 2001; 86(6): 2619-2624
62. Leslie H., Courtney C.H., Bell P.M., Hadden D.R. Laboratory and clinical expierence in 55 patient
with macroprolactinaemia identified by a simple polyethylene glycol precipitation method // Journal
of Clinical Endocrinology and Metabolism. - 2001; 86 (6): 2743-2746.
63. Levy M.J., Matharu M.S., Goadsby P.J. Prolactinomas, dopamine agonists and headache //
European Journal of Neurology. — 2003; 10: 169-173.
64. Brooks PL., Vella E.T., Wynne-Edwards K.E. Dopamine agonist treatment before and after the
birth reduces prolactin concentration but does not impair paternal responsiveness in Djungarian
hamsters, Phodopus campbelli // Hormones and Behavior. - 2005; 47: 358-366.
65. Lombardo F., Gandini L., Santulli M., Jannini E.A., Dondero F, Lenzi A. Endocrinological
diagnosis in sexology // J. Endocrinol. Invest. — 2003; 26(3 Suppl): 112-114.
66. Ma E., Lau J., Grattan D.R., Lovejoy D.A. and Wynne-Edwards K.E. Male and Female Prolactin
Receptor mRNA Expression in the Brain of a Biparental and a Uniparental Hamster, Phodopus,
Before and After the Birth of a Litter // Journal of Neuroendocrinology. - 2005; Vol. 17: 81-90.
67. Masuzaki H., Paterson J., Shinyama H. et.al. A transgenic model of visceral obesity and the
metabolic syndrome // Science. - 2001; 294: 2166-2170.
68. McClellan K.A., Robertson F.G., Kindblom J., Wennbo H., Tornell J., Bouchard В., Kelly P.A.,
Ormandy C.J. Investigation of the role of prolactin in the development and function of the lacrimal
and harderian glands using genetically modified mice // Invest Ophthalmol Vis Sci. — 2001, Jan.;
42(1): 23-30.
69. Meaney A.M., O'Keane V. Prolactin and schizophrenia: clinical consequences of
hyperprolactinaemia // Life Sci. - 2002, Jul. 19; 71(9): 979-92
70. Medras M., Jankowska E.A. Hyperprolactinemia and sexual activity of men - clinical aspect // Pol.
Arch. Med. Wewn. - 2004, Mar.; 111(3): 327-331.
71. Men with Prolactinoma // The Journal of Clinical Endocrinology & Metabolism. - 89(6): 2770-
2775.
72. Molitch M.E. Medical treatment of prolactinomas // Endocrinol. Metab. Clin. North Am. - 1999,
Mar.; 28(1): 143-169, vii.
73. Molitch M.E. Disorders of prolactin secretion // Endocrinol. Metab. Clin. North Am. - 2001, Sep.;
30(3): 585-610.
74. Morton N.M., Paterson J.M., Masuzaki H., Holmes M.C. et al. Novel adipose tissue - mediated
resistance to diet-induced visceral obesity in 117-hydroxysteroid dehydrogenase type 1 - deficient
mice // Diabetes. - 2004; Vol. 53.
75. Motta Т., de Vincentiis S., Marchini M., Colombo N., D'Alberton A. Vaginal cabergoline in the
treatment of hyperprolactinemic patients intolerant to oral dopaminergics // Fertil. Steril. - 1996,
Feb.; 65(2): 440-442.
76. Nagi D.K., Vani D.H. Diabetic fatty liver. Diabetes UK // Diabetic Medicine. -2005; 22: 1-21.
77. Olukoga A.O. Macroprolactinaemia is clinically important // Journal of Clinical Endocrinology and
Metabolism. - 2002; 87(10): 4833-4834.
78. Olukoga A.O., Kane J.W. Macroprolactinaemia: validation and application of the polyethylene
glycol precipitation test and clinical characterization of the condition // Clin. Endocrinol. - 1999; 51:
119.
79. Del Dotto P., Gambaccini G., Caneparo D., Berti С. Bedtime cabergoline in Parkinson's disease
patients with excessive daytime sleepiness induced by dopamine agonists // Neurol. Sci. — 2003;
24: 170-171.